KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $4.7 billion.

  • Resmed's Non-Current Assets rose 881.3% to $4.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.7 billion, marking a year-over-year increase of 881.3%. This contributed to the annual value of $4.7 billion for FY2025, which is 341.36% up from last year.
  • Resmed's Non-Current Assets amounted to $4.7 billion in Q4 2025, which was up 881.3% from $4.7 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Non-Current Assets ranged from a high of $4.7 billion in Q4 2025 and a low of $3.1 billion during Q1 2021
  • Moreover, its 5-year median value for Non-Current Assets was $4.4 billion (2023), whereas its average is $4.0 billion.
  • In the last 5 years, Resmed's Non-Current Assets soared by 4110.67% in 2023 and then plummeted by 490.07% in 2024.
  • Quarter analysis of 5 years shows Resmed's Non-Current Assets stood at $3.2 billion in 2021, then surged by 36.5% to $4.4 billion in 2022, then grew by 4.05% to $4.5 billion in 2023, then dropped by 4.9% to $4.3 billion in 2024, then increased by 8.81% to $4.7 billion in 2025.
  • Its last three reported values are $4.7 billion in Q4 2025, $4.7 billion for Q3 2025, and $4.7 billion during Q2 2025.